评估新型肺炎球菌疫苗免疫性,开发和许可的方法
Feroze A Ganaie1, Moon H Nahm1
1Division of Pulmonary/Allergy/Critical Care, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.
Human vaccines & immunotherapeutics
|August 13, 2025
概括
评估肺炎球菌合疫苗 (PCV) 对于预防肺炎球菌感染至关重要. 本综述详细介绍了WHO-ELISA和opsonophagocytic测试等方法,以评估PCV疗效并指导未来的疫苗开发.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 肺炎球菌结合疫苗 (PCV) 显著减少了链球菌肺炎感染.
- 诸如血清型替代和疫苗逃脱等挑战需要持续的PCV评估和改进.
研究的目的:
- 审查评估肺炎球菌疫苗疗效的核心方法,从开发到许可.
- 强调对下一代PCV进行持续评估的重要性.
主要方法:
- 世卫组织与酶相关的免疫吸收试验 (ELISA) 用于量化血清型特异性IgG水平.
- 奥普松细胞测定 (OPA) 用于评估功能性抗体活性和相关的保护.
- 对免疫质量和耐用性进行抗体激发和B细胞记忆反应的评估.
主要成果:
- 已建立的方法为PCV评估提供了坚实的框架.
- 功能性抗体测试 (OPA) 作为保护的相关物.
- 贪和记忆B细胞评估为疫苗诱导的免疫提供了更深入的见解.
结论:
- 审查的方法支持基于证据的现有和下一代PCV许可证.
- 这些评估为预防肺炎球菌病的公共卫生战略提供了信息.
- 持续评估是解决肺炎球菌疾病控制不断变化的挑战的关键.
相关概念视频
Pneumonia III: Complications and Assessment
437
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
437
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Vaccinations
45.3K
Overview
45.3K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K


